Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
PaperCitations, authors & open-access status
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 291 citations, 2019 year and hybrid oa status.
291
Citations
2019
Year
hybrid
OA Status